Copyright 2024 SPARK

Hereditary cancer tests help patients understand their risk of cancer, providing actionable results and allowing them to proactively manage their medical care. Therefore, accurate classification of variants in hereditary cancer genes is of paramount importance. Clinical genomics scientists face unique challenges in classifying splice variants, requiring a diverse team of experts and an array of tools to meet these challenges.

In this webinar, hosted by Genomenon, Inc., Randi Rawson, PhD of Myriad Genetics, will discuss the multifaceted approach that brings together RNA analysis, functional evidence in the literature, published clinical cases, and other methods to classify splice variants. She will share how the Mastermind Genomic Search Engine facilitates the clustering of publications for variants that share a common mechanism, and how a critical review of all available evidence is crucial for interpreting splice variants. Dr. Rawson will be joined by Genomenon’s Field Application Scientist and Mastermind Expert, Denice Belandres.

You Will Learn:

  • How interpreting splice variants represents a unique challenge in hereditary cancer genes and directly impacts patient risk mitigation and care
  • How determining whether a splice variant causes a partial or complete defect can alter variant classification
  • How multidisciplinary teams employ multiple tools like RNA analysis, computational predictions, literature, and clinical data for a comprehensive approach

Are you confident that you have all the evidence you need for variant interpretation? Create your account today to increase your diagnostic yield and make sure you’re not missing evidence with Mastermind, the comprehensive genomic search engine.